Conmed (CNMD) Profit After Tax (2010 - 2026)

Conmed (CNMD) has reported Profit After Tax for 17 consecutive years, with $24.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Profit After Tax fell 5.61% year-over-year to $24.4 million; the trailing twelve-month figure through Jun 2026 stood at $66.1 million (down 43.05% YoY), and the FY2025 full-year result was $59.6 million, down 54.98% from the prior year.
• Profit After Tax rose to $24.4 million in Q2 2026 per CNMD's latest filing, from $15.4 million in the prior quarter.
• Across five years, Profit After Tax topped out at $49.0 million in Q3 2024 and bottomed at -$172.6 million in Q2 2022.
• Historically, Profit After Tax has averaged $12.2 million across 5 years, with a median of $19.9 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Profit After Tax slumped 1072.98% in 2022, then jumped 327.65% in 2024.
• Over 5 years, Profit After Tax stood at $28.9 million in 2022, then grew by 27.72% to $36.9 million in 2023, then declined by 8.42% to $33.8 million in 2024, then slumped by 41.71% to $19.7 million in 2025, then rose by 23.94% to $24.4 million in 2026.
• According to Business Quant data, Profit After Tax over the past three periods registered $24.4 million, $15.4 million, and $19.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.